Why MFS Emerging Markets Equity A (MEMAX) Worth Another Look?

MEMAX

MFS Emerging Markets Equity A Fund (MEMAX - Free Report) seeks capital appreciation. MEMAXinvests, under normal market conditions, at least 80% of its net assets in common stocks and related securities, such as preferred stock, convertible securities and depositary receipts, of emerging market issuers. Emerging market issuers are issuers whose principal activities are located in emerging market countries. Emerging market countries include any country determined to have an emerging market economy, taking into account a number of factors, including whether the country has a low-to-middle-income economy according to the International Bank for Reconstruction and Development (the World Bank), the country's foreign currency debt rating, its political and economic stability and the development of its financial and capital markets. 

This Non US - Equity product has a history of positive total returns for over 10 years.  Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 5.4% and 5 year 3.4%. To see how this fund performed compared in its category, and #1 and #2 Ranked Mutual Funds, please click here.  

The MFS Emerging Markets Equity A fund, as of the last filing, allocates their fund in top two major groups; Emerging Market and Intermediate Bond. Further, as of the last filing, Alibaba Group Holding Ltd ADR, Samsung Electronics Co Ltd and Taiwan Semiconductor Manufacturing Co Ltd were the top holdings for MEMAX.

This Zacks Rank #1 (Strong Buy) was incepted in October 1995 and is managed by MFS. MEMAX carries an expense ratio of 1.50% and requires a minimal initial investment of $1,000.

Want key mutual fund info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>